Can cefuroxime precipitate or exacerbate Henoch‑Schönlein purpura–like vasculitis in a 13‑year‑old boy with HSP and streptococcal tonsillitis?

Can Cefuroxime Trigger HSP-Like Vasculitis?

Yes, cefuroxime can trigger Henoch-Schönlein purpura-like vasculitis, as documented in a case report of drug-related HSP with important systemic manifestations including glomerulonephritis with IgA mesangial deposits. 1

Evidence for Drug-Induced HSP

The direct evidence linking cefuroxime to HSP comes from a published case where a patient developed HSP during treatment with cefuroxime and diclofenac, presenting with:

• Purpuric rash
• Glomerulonephritis with IgA mesangial deposits
• Important systemic manifestations 1

The cefuroxime was considered the most likely culprit because the same patient had experienced a purpuric rash after taking cephradine (another cephalosporin) for mastitis ten years earlier, suggesting a class effect. 1

HSP Pathophysiology and Triggers

HSP is fundamentally an IgA-mediated, autoimmune, hypersensitivity vasculitis that commonly follows infectious triggers but can also be precipitated by:

• Infectious agents (especially group A streptococci and Mycoplasma) 2
• Drug allergies 2
• Food reactions 2
• Insect bites 2
• Exposure to cold 2

The mechanism involves small-vessel vasculitis with IgA deposition, and drugs can serve as antigenic triggers for this immune-mediated process. 3, 4

Clinical Context: Streptococcal Tonsillitis Complicating the Picture

In your 13-year-old patient with both HSP and streptococcal tonsillitis, the clinical situation is particularly complex because:

• HSP commonly follows upper respiratory tract infections, with group A streptococci being one of the most frequent infectious triggers. 2, 3
• The streptococcal infection itself could be triggering or exacerbating the HSP, independent of any antibiotic effect. 5
• Cefuroxime exposure adds a second potential trigger on top of the streptococcal infection. 1

Practical Management Algorithm

When HSP develops or worsens during cefuroxime treatment for streptococcal tonsillitis:

1. Discontinue cefuroxime immediately – the drug-related HSP case demonstrated serious systemic involvement including glomerulonephritis 1

2. Switch to a non-cephalosporin antibiotic – consider penicillin or amoxicillin for streptococcal coverage, as these are structurally distinct and the cross-reactivity risk is lower 1

3. Monitor for HSP progression – assess for:

   • Worsening purpuric rash on lower extremities
   • Abdominal pain or gastrointestinal hemorrhage
   • Arthritis or arthralgia
   • Renal involvement (hematuria, proteinuria, hypertension) 4

4. Initiate supportive care – most HSP cases are self-limited with an average duration of 4 weeks 4

5. Consider corticosteroids only for specific indications:

   • Severe gastrointestinal pain
   • Gastrointestinal hemorrhage
   • Note: Current evidence does not support universal corticosteroid treatment, and early steroids do not reduce nephropathy incidence. 4

Critical Monitoring Requirements

Renal surveillance is mandatory because renal involvement is the most important prognostic factor determining morbidity and mortality in HSP: 4

• Monitor blood pressure for hypertension 5
• Check urinalysis for hematuria and proteinuria 4
• If proteinuria persists beyond 3 months or severe nephritis develops, add an ACE inhibitor or angiotensin receptor blocker to prevent secondary glomerular injury. 4

Common Pitfalls to Avoid

• Do not assume the HSP is solely infection-related when a cephalosporin is being administered – the drug may be contributing or causative 1
• Do not continue cefuroxime if HSP symptoms worsen – the documented case showed serious systemic involvement including glomerulonephritis 1
• Do not fail to establish long-term renal monitoring – persistent hypertension and end-stage kidney disease are rare but serious complications 4
• Do not use corticosteroids routinely – they are indicated only for severe gastrointestinal manifestations and do not prevent nephropathy 4